Rane Pharmaceuticals is a company committed to excellence and as such seeks to employ the brightest most capable, and dedicated professionals in the field. With a team of several highly qualified researchers, including chemists with Ph.Ds specializing in both medicinal and organic chemistry. With decades of experience in the field of research and development, our staff of enthusiastic and innovative personnel possess outstanding skills in research chemistry that allow them to find new, inventive, and effective solutions to all of the projects they work on.
Dr Mohammad Rahim, CSO of Rane Pharmaceuticals received his Ph.D degree in synthetic organic chemistry from Tokyo University of Agriculture and Technology, while studying under the direction of Professor Takeshi Takeda. He obtained postdoctoral research training funded by CIHR at the Department of Pharmacy and Pharmaceutical Science under the supervision of Dr. Ed Knaus. His research work focused on drug design synthesis and biological evaluation, specializing in the field of anti inflammatory and cardiovascular areas.
Dr. Rahim started his professional career at Naeja Pharmaceutical Inc located in Edmonton, Alberta as a research scientist and then later moved on to be a principal scientist. During twelve years of his work at Naeja Pharmaceuticals he was involved in the process of drug discovery in the area of anticancer, antibacterial, anti inflammatory, and cardiovascular and CNS research.
During his time at Naeja, his contract research experience included team collaboration with Pfizer, AstraZeneca, AnaCor, Aicuris, Boehringer Ingelheim etc. He took part in the discovery of different antibacterial and anti inflammatory compounds which are now in phase three clinical trials. He is the co-author of many US and international patents. In addition, some of his work has also been published in various international journals and presented at conferences.